Lixte Biotechnology Holdings (LIXT) Equity Ratio (2016)
Lixte Biotechnology Holdings' Equity Ratio history spans 7 years, with the latest figure at 0.79 for Q3 2016.
- For Q3 2016, Equity Ratio rose 0.87% year-over-year to 0.79; the TTM value through Sep 2016 reached 0.79, up 0.87%, while the annual FY2015 figure was 0.52, N/A changed from the prior year.
- Equity Ratio reached 0.79 in Q3 2016 per LIXT's latest filing, down from 0.9 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.9 in Q2 2016 to a low of 1.32 in Q1 2012.
- Average Equity Ratio over 5 years is 0.57, with a median of 0.79 recorded in 2015.
- Peak YoY movement for Equity Ratio: skyrocketed 362.84% in 2012, then tumbled 162.73% in 2014.
- A 5-year view of Equity Ratio shows it stood at 0.85 in 2012, then crashed by 50.25% to 0.42 in 2013, then surged by 40.8% to 0.6 in 2014, then dropped by 12.38% to 0.52 in 2015, then skyrocketed by 51.35% to 0.79 in 2016.
- Per Business Quant, the three most recent readings for LIXT's Equity Ratio are 0.79 (Q3 2016), 0.9 (Q2 2016), and 0.84 (Q1 2016).